GO:0002450 B cell antigen processing and presentation: Antigen Presentation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002450 describes the biological process by which a B cell expresses antigen (peptide or lipid) on its surface in association with an MHC protein complex.
• B cells act as professional antigen-presenting cells, capturing, processing, and presenting antigens to CD4+ T cells, thereby shaping adaptive immunity.
• The process is critical for memory B cell maintenance, differentiation, and the formation of tertiary lymphoid structures in tumors.
• Key molecular players include the B cell receptor (BCR), MHC class II molecules, cathepsins, and the invariant chain (CD74).
• Dysregulation of B cell antigen presentation is implicated in autoimmune diseases such as multiple sclerosis and in cancer immunity.
• CRISPR-based models (knockout, knock-in, point mutation) enable precise dissection of genes controlling B cell antigen processing and presentation.
Description
B cell antigen processing and presentation (GO:0002450) is a fundamental biological process in which B lymphocytes internalize, process, and display antigenic peptides or lipids on their surface in association with MHC molecules. This process is essential for the activation of CD4+ T cells and for the coordination of adaptive immune responses. Unlike other antigen-presenting cells, B cells use their B cell receptor (BCR) to specifically capture antigens, allowing for efficient presentation at low antigen concentrations. The importance of this process extends to memory B cell maintenance, antibody production, and the formation of tertiary lymphoid structures in chronic inflammation and cancer. Researchers study GO:0002450 to understand immune regulation, autoimmunity, and to develop targeted immunotherapies.
B cell antigen processing and presentation At A Glance
| GO ID | GO:0002450 |
|---|---|
| GO term | B cell antigen processing and presentation |
| Ontology | biological_process |
| Synonym | B-cell antigen processing and presentation; B lymphocyte antigen processing and presentation; B-lymphocyte antigen processing and presentation |
| Major function | Antigen uptake, processing, and presentation on MHC molecules to T cells |
| Key cell type | B lymphocytes |
| Associated molecules | BCR, MHC class II, CD74, cathepsins |
| Disease relevance | Autoimmunity, cancer, multiple sclerosis |
What Is GO:0002450?
GO:0002450, B cell antigen processing and presentation, is defined as the process in which a B cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. This encompasses antigen uptake, intracellular processing, and loading onto MHC molecules for recognition by T cells.
Why Is B cell antigen processing and presentation Important in Cell Biology?
B cell antigen processing and presentation is central to adaptive immunity because it bridges innate antigen recognition with T cell activation, influencing memory formation, autoantibody production, and anti-tumor responses. Understanding this process provides insights into vaccine design, autoimmune pathogenesis, and cancer immunotherapy.
• Enables B cells to present antigens to CD4+ T cells, a prerequisite for T cell-dependent antibody responses.
• Supports memory B cell maintenance and differentiation.
• Contributes to the formation of tertiary lymphoid structures in tumors, which correlate with better prognosis.
• Dysregulation can lead to autoimmune diseases such as multiple sclerosis.
• Plays a role in anti-tumor immunity and response to checkpoint inhibitors.
• Provides a target for therapeutic intervention in autoimmunity and cancer.
• Involves specialized intracellular trafficking and cell polarity mechanisms.
• Is modulated by pathogen-derived factors, e.g., EBV infection.
What Happens During B cell antigen processing and presentation?
Antigen recognition and uptake
In simple terms: B cells grab antigens using their B cell receptor.
B cells specifically bind antigens via the B cell receptor (BCR), which triggers receptor-mediated endocytosis and delivers the antigen to endosomal compartments. This step is highly efficient and allows B cells to capture antigens even at low concentrations.
Antigen processing in endosomes
In simple terms: The antigen is chopped into smaller pieces inside the cell.
Internalized antigens are degraded by proteases such as cathepsins in endosomes/lysosomes, generating peptides that can bind MHC class II molecules. The invariant chain (CD74) is removed, and peptides are loaded onto MHC class II in the MHC class II compartment (MIIC).
MHC class II loading and surface presentation
In simple terms: The chopped antigen is placed on a carrier and sent to the cell surface.
Peptide-loaded MHC class II molecules are transported to the plasma membrane for presentation to CD4+ T cells. This process is regulated by cell polarity and cytoskeletal dynamics.
T cell recognition and immune synapse formation
In simple terms: T cells recognize the presented antigen and form a connection.
CD4+ T cells recognize the MHC class II-peptide complex via their T cell receptor, leading to immune synapse formation and T cell activation. This interaction is critical for B cell differentiation and memory maintenance.
Key Genes Involved in GO:0002450 B cell antigen processing and presentation
The following genes and proteins are key players in B cell antigen processing and presentation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCR (IgH/IgL) | Antigen recognition and uptake | Target for knockout to study antigen capture |
| MHC class II (HLA-DR, etc.) | Peptide loading and presentation | Knockout models to assess T cell activation |
| CD74 (invariant chain) | Chaperone for MHC class II | Knockout affects peptide loading |
| Cathepsin S | Antigen processing | Inhibitors or KO to block degradation |
| Cathepsin L | Antigen processing | KO models show impaired presentation |
| HLA-DM | Peptide editing | Knockout alters peptide repertoire |
| HLA-DO | Modulates HLA-DM | Overexpression studies |
| CD40 | Costimulation | KO impairs T-B interaction |
| CD80/CD86 | Costimulation | KO reduces T cell activation |
| ICAM-1 | Adhesion | KO affects immune synapse |
| LFA-1 | Adhesion | KO affects synapse stability |
| Rho GTPases | Cytoskeletal dynamics | KO affects antigen extraction |
| Myosin II | Cell polarity | KO impairs antigen processing |
| EBV proteins (e.g., LMP1) | Modulate antigen presentation | Infection models |
| TLR9 | Innate sensing | KO affects B cell activation |
| IL-10 | Regulation | Overexpression suppresses presentation |
| TRAF3 | Signaling | KO alters B cell function |
How Is B cell antigen processing and presentation Regulated?
B cell antigen processing and presentation is regulated at multiple levels, including antigen internalization, endosomal trafficking, and MHC class II expression. Cell polarity and cytoskeletal rearrangements are critical for efficient antigen extraction and presentation. Cytokines such as IL-10 can suppress presentation, while costimulatory molecules enhance T cell activation. Pathogens like EBV can modulate HLA-DR expression and antigen presentation, contributing to autoimmunity.
B cell antigen processing and presentation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HLA-DR15 | Multiple sclerosis | Knock-in mice expressing HLA-DR15 |
| EBV LMP1 | Lymphoproliferative disorders | B cell lines with LMP1 overexpression |
| MHC class II | Autoimmunity | Knockout mice |
| Cathepsin S | Autoimmune arthritis | Cathepsin S inhibitors |
| CD74 | Lymphoma | CD74 knockout B cells |
Autoimmune diseases
Dysregulated B cell antigen presentation is implicated in autoimmune conditions such as multiple sclerosis, where EBV infection and HLA-DR15 jointly drive myelin peptide presentation. B cells can present self-antigens to autoreactive T cells, perpetuating inflammation.
Cancer
B cells in tertiary lymphoid structures present tumor antigens and influence anti-tumor immunity. Their antigen presentation capacity correlates with improved responses to immunotherapy.
Infectious diseases
Pathogens can evade or exploit B cell antigen presentation; for example, EBV modulates MHC class II presentation to promote immune evasion.
From B cell antigen processing and presentation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of BCR in antigen uptake | BCR knockout B cell lines |
| MHC class II peptide loading | CD74 knockout mice |
| Cytoskeletal regulation of presentation | Rho GTPase knockout B cells |
| EBV modulation of antigen presentation | EBV-infected B cell lines |
| Costimulation in T cell activation | CD40 knockout mice |
| Therapeutic targeting of antigen presentation | Humanized mouse models |
How to Study the B cell antigen processing and presentation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface MHC class II, costimulatory molecules | B cell phenotyping |
| Confocal microscopy | Antigen uptake and synapse formation | Live-cell imaging |
| Mass spectrometry | MHC class II peptide repertoire | Immunopeptidomics |
| ELISPOT | Cytokine secretion by T cells | T cell activation |
| CRISPR screening | Genes required for antigen presentation | Functional genomics |
| RNA-seq | Transcriptional profiling | Gene expression analysis |
| Western blot | Protein expression | Validation of knockouts |
Flow cytometry
Flow cytometry is used to measure surface MHC class II and costimulatory molecules on B cells, assessing antigen presentation capacity.
Imaging
Confocal microscopy visualizes antigen uptake, endosomal trafficking, and immune synapse formation between B and T cells.
Proteomics
Mass spectrometry identifies peptides presented on MHC class II, revealing the immunopeptidome.
Functional T cell assays
Co-culture of B cells with antigen-specific CD4+ T cells measures T cell activation and proliferation.
How CRISPR Can Be Used to Study GO:0002450 B cell antigen processing and presentation
Knockout
CRISPR knockout of genes such as BCR, MHC class II, or cathepsins in B cell lines or primary B cells can reveal their essential roles in antigen processing and presentation.
Point Mutation
Point mutations can be introduced into MHC class II or CD74 to study peptide binding and editing, mimicking human disease-associated variants.
Knock-in
Knock-in of tagged MHC class II or BCR allows for tracking and purification of antigen-presenting complexes.
Overexpression
Overexpression of costimulatory molecules or cytokines can enhance or suppress antigen presentation, enabling functional studies.
How EDITGENE Supports B cell antigen processing and presentation Research
Researchers studying B cell antigen processing and presentation-related genes often need to determine whether a candidate gene is causally involved in antigen uptake, processing, or T cell activation. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for B cell antigen processing and presentation research.
Frequently Asked Questions About B cell antigen processing and presentation
What is B cell antigen processing and presentation?
It is the process by which B cells internalize, process, and present antigens on MHC molecules to T cells.
What genes are involved in B cell antigen processing and presentation?
Key genes include BCR, MHC class II, CD74, cathepsins, and costimulatory molecules.
What is GO:0002450?
GO:0002450 is the Gene Ontology term for B cell antigen processing and presentation.
How do B cells present antigens?
B cells capture antigens via BCR, degrade them in endosomes, and load peptides onto MHC class II for surface presentation.
Why is B cell antigen presentation important?
It is essential for T cell activation, memory B cell maintenance, and immune responses to pathogens and tumors.
What diseases are associated with defects in B cell antigen presentation?
Autoimmune diseases like multiple sclerosis and cancers.
What methods are used to study B cell antigen presentation?
Flow cytometry, imaging, proteomics, and CRISPR screens.
Can CRISPR be used to study B cell antigen presentation?
Yes, knockout, knock-in, and point mutation models enable precise gene function studies.
What is the role of MHC class II in B cell antigen presentation?
MHC class II molecules display processed peptides to CD4+ T cells.
How does EBV affect B cell antigen presentation?
EBV can modulate HLA-DR expression and contribute to autoimmunity.
Conclusion
B cell antigen processing and presentation (GO:0002450) is a cornerstone of adaptive immunity, with profound implications for autoimmunity, cancer, and infectious diseases. Advances in CRISPR technology and functional genomics are accelerating our understanding of this process, offering new therapeutic avenues.
References
- 1. Fridman WH et al.. 2023. Tertiary lymphoid structures and B cells: An intratumoral immunity cycle.. Immunity 56(10):2254-2269 PMID: 37699391
- 2. Rastogi I et al.. 2022. Role of B cells as antigen presenting cells.. Front Immunol 13:954936 PMID: 36159874
- 3. Reis e Sousa C et al.. 2014. Antigen processing.. Curr Opin Immunol 26:138-9 PMID: 24556410
- 4. Welsh RA et al.. 2021. How Does B Cell Antigen Presentation Affect Memory CD4 T Cell Differentiation and Longevity?. Front Immunol 12:677036 PMID: 34177919
- 5. Obino D et al.. 2014. A critical role for cell polarity in antigen extraction, processing, and presentation by B lymphocytes.. Adv Immunol 123:51-67 PMID: 24840947
- 6. Shimoda M et al.. 2007. MHC-restricted B-cell antigen presentation in memory B-cell maintenance and differentiation.. Crit Rev Immunol 27(1):47-60 PMID: 17430096
- 7. Wang J et al.. 2026. EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation.. Cell 189(2):569-584.e14 PMID: 41534530
- 8. Heesters BA et al.. 2016. Antigen Presentation to B Cells.. Trends Immunol 37(12):844-854 PMID: 27793570
